219 related articles for article (PubMed ID: 24685380)
1. New approach to implantable cardioverter-defibrillators in small pediatric patients: dorsal positioning of superior vena cava shock lead in a 3-year-old.
Pedersen SB; Smerup MH; Nielsen JC
J Thorac Cardiovasc Surg; 2014 Jul; 148(1):358-60. PubMed ID: 24685380
[No Abstract] [Full Text] [Related]
2. Abdominal submuscular implant of subcutaneous implantable cardioverter-defibrillator in a young child.
Kwok SY; Yam N; Lun KS; Chen RH; Au TW; Yung TC
Europace; 2018 Sep; 20(FI2):f248. PubMed ID: 29401320
[No Abstract] [Full Text] [Related]
3. Transvenous ICD lead malposition in the left ventricle: long-term follow-up.
Franck H; Wollschläger H
Clin Res Cardiol; 2013 Feb; 102(2):159-61. PubMed ID: 22868694
[No Abstract] [Full Text] [Related]
4. Seventh try's a charm: ventricular fibrillation terminated by the seventh shock.
Li J; Zitron E; Katus HA; Becker R
Circ Arrhythm Electrophysiol; 2011 Apr; 4(2):e4-6. PubMed ID: 21505170
[No Abstract] [Full Text] [Related]
5. Relationship of Shock Energy to Impedance During Subcutaneous Implantable Cardioverter-Defibrillator Testing.
Payne JE; Badertscher P; Field ME; Sturdivant JL; Gold MR
Circ Arrhythm Electrophysiol; 2020 Sep; 13(9):e008631. PubMed ID: 32703008
[No Abstract] [Full Text] [Related]
6. Recent developments in the subcutaneous ICD.
Willcox ME; Prutkin JM; Bardy GH
Trends Cardiovasc Med; 2016 Aug; 26(6):526-35. PubMed ID: 27079889
[TBL] [Abstract][Full Text] [Related]
7. [Transcripts from automated external defibrillator are important].
Lynge TH; Risgaard B; Philbert B; Winkel BG; Tfelt-Hansen J
Ugeskr Laeger; 2014; 176(34):. PubMed ID: 25850431
[TBL] [Abstract][Full Text] [Related]
8. Combining shock reduction strategies to enhance ICD therapy: a role for computer modeling.
Volosin KJ; Exner DV; Wathen MS; Sherfesee L; Scinicariello AP; Gillberg JM
J Cardiovasc Electrophysiol; 2011 Mar; 22(3):280-9. PubMed ID: 20958831
[TBL] [Abstract][Full Text] [Related]
9. Antitachycardia pacing therapy for the successful treatment of lead fracture.
Bhimani AA; Deeprasertkul P; Nannapaneni N; Carayannopoulos GN
J Cardiovasc Electrophysiol; 2015 Feb; 26(2):228-9. PubMed ID: 25354719
[No Abstract] [Full Text] [Related]
10. Beyond the implantable cardioverter-defibrillator: are we making progress?
Weiss JN
Heart Rhythm; 2008 Jun; 5(6 Suppl):S45-7. PubMed ID: 18456201
[TBL] [Abstract][Full Text] [Related]
11. Conductor externalization of the RIATA implantable cardioverter defibrillator lead: a challenging lead extraction requiring laser-powered sheath.
Migliore F; Bertaglia E; Bontempi L; Verlato R; Leoni L; Iliceto S; Curnis A
J Cardiovasc Med (Hagerstown); 2013 Oct; 14(10):755-6. PubMed ID: 23996009
[TBL] [Abstract][Full Text] [Related]
12. Defibrillation for Ventricular Fibrillation: A Shocking Update.
Nichol G; Sayre MR; Guerra F; Poole J
J Am Coll Cardiol; 2017 Sep; 70(12):1496-1509. PubMed ID: 28911514
[TBL] [Abstract][Full Text] [Related]
13. Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.
Proclemer A; Ghidina M
J Cardiovasc Med (Hagerstown); 2007 May; 8(5):320-3. PubMed ID: 17443096
[No Abstract] [Full Text] [Related]
14. Post-shock oversensing by a subcutaneous defibrillator resulting in inappropriate withholding of post-shock bradycardia pacing.
Maass AH; Van Gelder IC
Europace; 2014 Jul; 16(7):1032. PubMed ID: 24792457
[No Abstract] [Full Text] [Related]
15. HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials.
Kusumoto FM; Calkins H; Boehmer J; Buxton AE; Chung MK; Gold MR; Hohnloser SH; Indik J; Lee R; Mehra MR; Menon V; Page RL; Shen WK; Slotwiner DJ; Stevenson LW; Varosy PD; Welikovitch L
Circulation; 2014 Jul; 130(1):94-125. PubMed ID: 24815500
[No Abstract] [Full Text] [Related]
16. Prolonged sustained ventricular fibrillation in a patient with dextrocardia and a left ventricular assist device.
Bolzan B; Morani G; Tomei R; Tomasi L; Borio G; Ribichini FL
J Cardiovasc Med (Hagerstown); 2019 Oct; 20(10):721-724. PubMed ID: 31389822
[No Abstract] [Full Text] [Related]
17. Wearable cardioverter-defibrillator as a bridge to implantable cardioverter-defibrillator treatment.
Technol Eval Cent Assess Program Exec Summ; 2010 Nov; 25(2):1-5. PubMed ID: 21638938
[No Abstract] [Full Text] [Related]
18. Primary prevention of sudden cardiac death: one step forwards and one step backwards.
Cain ME
Nat Clin Pract Cardiovasc Med; 2006 Mar; 3(3):115. PubMed ID: 16505838
[No Abstract] [Full Text] [Related]
19. Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia in patients with an implantable defibrillator warrants catheter ablation.
Kuck KH
Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):713-20; discussion 720. PubMed ID: 20009082
[No Abstract] [Full Text] [Related]
20. Ventricular fibrillation storm in a child.
Einbinder T; Lowenthal A; Fogelman R
Europace; 2014 Nov; 16(11):1654. PubMed ID: 25344961
[No Abstract] [Full Text] [Related]
[Next] [New Search]
